Showing results (2011-2020 of 2,055) with videos related to

Sort By:
Pageof 206
Scientific Reports|September 25, 2021
Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomyZai-Lin Sheu, Chi-Ping Huang, Chao-Hsiang Chang, et al.
Cell|April 30, 2025
Selective requirement of glycosphingolipid synthesis for natural killer and cytotoxic T cellsTasha A Morrison, Jaelyn Vigee, Kevin A Tovar, et al.
Journal of Advanced Research|March 28, 2024
Decoding and reconstructing disease relations between dry eye and depression: a multimodal investigation comprising meta-analysis, genetic pathways and Mendelian randomizationKao-Jung Chang, Hsin-Yu Wu, Pin-Hsuan Chiang, et al.
Nature Materials|March 24, 2026
Perovskite-organic tandem solar cells with superior reverse-bias stabilityJiaming Huang, Yu Han, Zhiwei Ren, et al.
Cancer Prevention Research (Philadelphia, Pa.)|September 11, 2021
The Relationship Between Breast Density Change During Menopause and the Risk of Breast Cancer in Korean WomenDanbee Kang, Ji-Yeon Kim, Ji-Young Kim, et al.
Nature|March 26, 2021
Neuronal enhancers are hotspots for DNA single-strand break repairWei Wu, Sarah E Kargbo-Hill, William J Nathan, et al.
Nature Immunology|May 10, 2016
BACH2 regulates CD8(+) T cell differentiation by controlling access of AP-1 factors to enhancersRahul Roychoudhuri, David Clever, Peng Li, et al.
Cell|September 27, 2016
A Functional Role for Antibodies in TuberculosisLenette L Lu, Amy W Chung, Tracy R Rosebrock, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|December 18, 2024
PD-L1 expression and immune profiling cannot predict osimertinib efficacy in lung cancer with EGFR T790 M mutation: A translational studyChing-Yao Yang, Wei-Yu Liao, Chao-Chi Ho, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trialsGui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, et al.
Pageof 206